| FSMDX | PARMX | FSMDX / PARMX | |
| Total Expense Ratio | 0.03 | 0.95 | 3% |
| Annual Report Gross Expense Ratio | 0.03 | 0.95 | 3% |
| Fund Existence | 14 years | 21 years | - |
| Gain YTD | 4.197 | 5.324 | 79% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 45.8B | 2.56B | 1,793% |
| Annual Yield % from dividends | 1.10 | 0.21 | 530% |
| Returns for 1 year | 14.17 | 8.04 | 176% |
| Returns for 3 years | 45.82 | 13.98 | 328% |
| Returns for 5 years | 47.23 | -0.75 | -6,267% |
| Returns for 10 years | 188.12 | 78.77 | 239% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GCICX | 17.90 | 0.08 | +0.45% |
| Goldman Sachs Intl Eq Insghts C | |||
| FWOZX | 19.53 | N/A | N/A |
| Fidelity Advisor Women's Leadership Z | |||
| ASILX | 14.58 | -0.04 | -0.27% |
| AB Select US Long/Short I | |||
| IGSIX | 12.02 | -0.14 | -1.15% |
| Impax Global Social Leaders Inst | |||
| BRWSX | 27.06 | -0.37 | -1.35% |
| MFS Blended Research Growth Eq R2 | |||